IE
BMY.RT

Israel Englander’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Israel Englander’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,076,991
Closed -$10.4M – 6879
2020
Q4 		$10.4M Buy
15,076,991
+2,763,250
+22% +$5.89M 0.01% 1681
2020
Q3 		$27.7K Buy
12,313,741
+694,687
+6% +$1.98M 0.03% 606
2020
Q2 		$41.6M Sell
11,619,054
-354,010
-3% -$1.28M 0.06% 356
2020
Q1 		$45.5M Sell
11,973,064
-4,073,886
-25% -$13.4M 0.1% 176
2019
Q4 		$48.3M Buy
+16,046,950
New +$41.7M 0.06% 381

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $77B AUM 10.33% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Israel Englander's BMY.RT Position: Q1 2021 in Review

Israel Englander sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 15,076,991 shares — an estimated $10.4M sold.

Israel Englander first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $48.3M in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Israel Englander reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Israel Englander sold 15,076,991 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $10.4M.
  • Israel Englander first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Israel Englander's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $48.3M in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Millennium Management's 13F filing for Q1 2021, filed 17 May 2021.